MARSHALL WACE, LLP

Q1 2020 13F-HR Holdings

Location
London, X0
Holdings as of
3/31/2020
Date filed
5/15/2020
Form type
13F-HR
Num holdings
1,585
Total value ($000)
$10,011,787
Net value change ($000)
-4,538,087 (-31.2%)
New positions
655
Sold out positions
686
Turnover %
40.3%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/14/2020 Next filing: 8/13/2020 SEC filing

Snapshot: Change Analysis

Compared to Q4 2019
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
FIS 124,687 460.0%
LIN 103,641 3019.8%
V 91,591 2174.0%
Allergan plc 86,064 94.5%
TIFFANY & CO 77,094 1975.2%
Biohaven Pharmaceutical Holding Co Ltd. 73,594 539.5%
A 69,326 80.0%
AMZN 68,905 26.9%
SWK 68,712 1128.8%
NVDA 67,083 9542.4%
Top Reduces (Value $000, Stocks/ETFs)
BSX -247,642 -67.0%
ZTS -152,724 -43.1%
TFX -151,138 -55.3%
EBAY -148,598 -100.0%
TMO -126,759 -42.5%
PFE -110,570 -88.3%
GEN -108,538 -99.7%
AVTR -91,722 -89.8%
HD -91,501 -70.1%
DIS -84,069 -90.5%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 143,341 (1.4% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type